BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

IBP

All Eps Dividend Board Agm Q1 Q2 Q3

IBP 24-Jan-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2021 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.

IBP 11-Jan-2021

Mr. Md. Bellal Khan, one of the Sponsors of the Company, has expressed his intention to sell 3,91,851 (Bonus) shares out of his total holding of 37,64,860 shares of the Company at prevailing market price (in the Block Market) through Stock Exchange (DSE) within next 30 working days.

IBP 23-Nov-2020

Trading of the shares of the Company will resume on 24.11.2020 after record date.

IBP 22-Nov-2020

Trading of the shares of the Company will remain suspended on record date i.e., 23.11.2020.

IBP 18-Nov-2020

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 19.11.2020 to 22.11.2020. Trading of the shares of the Company will remain suspended on record date i.e., 23.11.2020.

IBP 17-Nov-2020

(Continuation news of IBP): Our opinion is not modified in respect of this matter. b) We draw attention to Note 2.20 of the financial statements, which describes that a number of transactions entered into by the company were cash transactions with prior board approval and this was due to suppliers' demand. Our opinion is not modified in respect of this matter. (end)

IBP 17-Nov-2020

The auditor of the Indo-Bangla Pharmaceuticals Limited has given the "Emphasis of Matter " paragraph in the Auditor's Report for the year ended on 30 June 2020. Emphasis of Matter: a)We draw attention to Note 2.14 (c) of the financial statements, which describes that the Nomination and Remuneration Committee (NRC) of the company reviewed all post employee benefits and the policies are under process for final review of the Board. (cont.)

IBP 15-Nov-2020

(Q1 Un-audited): EPS was Tk. 0.34 for July-September, 2020 as against Tk. 0.40 for July-September, 2019. NOCFPS was Tk. 0.23 for July-September, 2020 as against Tk. 0.20 for July-September, 2019. NAV per share was Tk. 13.95 as on September 30, 2020 and Tk. 13.61 as on June 30, 2020.

IBP 08-Nov-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2020 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2020.

IBP 28-Oct-2020

There will be no price limit on the trading of the shares of the Company on today (28.10.2020) for following its corporate declaration. however, as per the BSEC Order No. BSEC/CMRRCD/2001-07/04 dated March 19, 2020, the floor price shall be applicable accordingly.

Previous Next page